Surgery for Stage IV Gastric Cancer: The New Edge

[1]  H. Matsubara,et al.  Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy , 2020, Surgical Case Reports.

[2]  T. Ohtsuka,et al.  Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report , 2020, World Journal of Surgical Oncology.

[3]  G. Tiberio,et al.  Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer , 2020, Cancers.

[4]  J. Lunceford,et al.  Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer. , 2018, Archives of pathology & laboratory medicine.

[5]  L. Solaini,et al.  Surgical treatment of hepatic metastases from gastric cancer , 2018, Updates in Surgery.

[6]  Kazuhiro Yoshida,et al.  International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). , 2018 .

[7]  V. D. de Jesus,et al.  Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center , 2018, World Journal of Surgical Oncology.

[8]  F. Roviello,et al.  Factors influencing survival after hepatectomy for metastases from gastric cancer. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  S. Hahn,et al.  Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. , 2016, The Lancet. Oncology.

[10]  Y. Kodera,et al.  Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification , 2015, Gastric Cancer.

[11]  G. Tiberio,et al.  Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? , 2015, Annals of Surgical Oncology.

[12]  H. Nagano,et al.  High Survival in Patients Operated for Small Isolated Liver Metastases from Gastric Cancer: A Multi-institutional Study , 2014, World Journal of Surgery.

[13]  Y. Kodera,et al.  Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines , 2014, Gastric Cancer.

[14]  R. Haba,et al.  S-1 and the treatment of gastric cancer with peritoneal dissemination. , 2011, Experimental and therapeutic medicine.

[15]  B. Pockaj,et al.  Validation of the Updated 7th Edition AJCC TNM Staging Criteria for Gastric Adenocarcinoma , 2011, Journal of Gastrointestinal Surgery.

[16]  L. Rabeneck,et al.  Management of gastric cancer in Ontario , 2010, Journal of surgical oncology.

[17]  T. Sohn,et al.  Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. , 2009, Archives of surgery.